31 July 2026 | Friday | News
Curium™ announced it is advancing plans for a second cyclotron investment in Romania, reaffirming the company’s long-term commitment to expanding access to advanced nuclear medicine in the region and strengthening the country’s healthcare infrastructure.
Following an extensive assessment of market opportunities, technical requirements and regional infrastructure, Curium has identified a preferred location in the Cluj-Napoca region and a preferred local partner. Preparatory activities are now underway to support the next phase of the project.
The additional production capacity is intended to further strengthen supply for PET imaging, improve patient access to advanced diagnostic procedures and support the continued development of nuclear medicine services across Northern Romania and neighboring markets.
The proposed investment builds upon Curium’s established presence in Romania and the company’s continued focus on innovation, operational excellence and sustainable healthcare infrastructure.
Ciril Faia, CEO Curium International said: “Advancing this project reflects Curium’s confidence in Romania’s potential and our long-term commitment to helping strengthen access to essential nuclear medicine services across the region. By investing in additional capacity and working closely with local partners and healthcare stakeholders, we aim to support more reliable access to PET imaging and help advance diagnostic care for patients.”
© 2026 Biopharma Boardroom. All Rights Reserved.